Clinical pharmacology

Currow, D; Clark, K; Kleinig, P

Clinical pharmacology

Currow, D

Clark, K Kleinig, P

Permalink

Publisher:: Oxford University Press (OUP)
Publication Type:: Chapter
Citation:: Emergencies in Supportive and Palliative Care, 2024, pp. 59-82
Issue Date:: 2024-02

In Progress

	Filename	Description	Size
	23484507_15722050410005671.pdf	Published version	1.13 MB		View/Open

Copyright Clearance Process

Recently Added
In Progress
Open Access

This item is being processed and is not currently available.

Full metadata record

Field	Value	Language
dc.contributor.author	Currow, D https://orcid.org/0000-0003-1988-1250
dc.contributor.author	Clark, K
dc.contributor.author	Kleinig, P
dc.contributor.editor	Currow, D https://orcid.org/0000-0003-1988-1250
dc.contributor.editor	Clark, K
dc.contributor.editor	Kleinig, P
dc.date.accessioned	2024-11-11T22:47:37Z
dc.date.available	2024-11-11T22:47:37Z
dc.date.issued	2024-02
dc.identifier.citation	Emergencies in Supportive and Palliative Care, 2024, pp. 59-82
dc.identifier.isbn	0192898337
dc.identifier.uri	http://hdl.handle.net/10453/181845
dc.description.abstract	<jats:title>Abstract</jats:title> <jats:p>The interaction of medications with the person who has a life-limiting illness is critical to consider. Most people with a life-limiting illness have new medications introduced, while continuing their longer-term medications for their comorbid illnesses. Understanding the potential medication–person and medication–medication interactions is crucial to minimize harms and maximize benefits. In this setting, many people benefit from careful review of their medications to optimize their compliance with those medications that are most beneficial and, at the same time, to minimize harms.</jats:p>
dc.language	en
dc.publisher	Oxford University Press (OUP)
dc.relation.ispartof	Emergencies in Supportive and Palliative Care
dc.relation.isbasedon	10.1093/med/9780192898333.003.0002
dc.rights	info:eu-repo/semantics/restrictedAccess
dc.title	Clinical pharmacology
dc.type	Chapter
pubs.organisational-group	University of Technology Sydney
pubs.organisational-group	University of Technology Sydney/Faculty of Health
pubs.organisational-group	University of Technology Sydney/UTS Groups
pubs.organisational-group	University of Technology Sydney/UTS Groups/Improving Palliative, Aged and Chronic Care through Clinical Research and Translation (IMPACCT)
utslib.copyright.status	in_progress	*
dc.date.updated	2024-11-11T22:47:36Z
pubs.publication-status	Published

Abstract:

Abstract The interaction of medications with the person who has a life-limiting illness is critical to consider. Most people with a life-limiting illness have new medications introduced, while continuing their longer-term medications for their comorbid illnesses. Understanding the potential medication–person and medication–medication interactions is crucial to minimize harms and maximize benefits. In this setting, many people benefit from careful review of their medications to optimize their compliance with those medications that are most beneficial and, at the same time, to minimize harms.

Please use this identifier to cite or link to this item:

http://hdl.handle.net/10453/181845